Crystal and molecular structures of 1,4-dihydro-6-methyl-5-N,N-diethylcarbamoyl-4-phenyl-2(3H)-pyrimidinethione (1) and 1,4-dihydro-6-methyl-5-N-methyl carbamoyl-4-(2′-nitrophenyl)-2(3H)-pyrimidinethione hemihydrate (2)

被引:3
作者
Mohan, KC
Ravikumar, K [1 ]
Shetty, MM
Thiyagarajan, S
Rajan, SS
机构
[1] Indian Inst Chem Technol, Lab Xray Crystallog, Hyderabad 500007, Andhra Pradesh, India
[2] Indian Inst Chem Technol, Div Organ Chem, Hyderabad 500007, Andhra Pradesh, India
[3] Univ Madras, Dept Crystallog & Biophys, Madras 600025, Tamil Nadu, India
关键词
crystal structure; dihydropyrimidines; carbamoyl substitution; calcium channel antagonists;
D O I
10.1023/A:1023270708250
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The crystal structure of 1,4-dihydro-6-methyl-5-N,N-diethylcarbamoyl-4-phenyl-2(3H)-pyrimidinethione, C16H21N3OS (1), is monoclinic, space group P2(1)/n, a = 6.818(1), b = 13.211(2), c = 18.807(3) Angstrom, = 99.53(1)degrees, V = 1670.6(4) Angstrom(3), Z = 4 and d(cal) = 1.206 Mg/m(3), R = 0.042 (wR = 0.119) for 190 parameters and 2560 observations with I greater than or equal to 2sigma(I) and 1,4-dihydro-6-methyl-5-N-methyl carbamoyl-4-(20-nitrophenyl)-2(3H)-pyrimidinethione hemihydrate, C13H14N4O3S . 0.5H(2)O, (2), is triclinic, space group P1, a = 7.513(1), b = 14.381(2), c = 15.506(2) Angstrom, alpha = 114.95(2), = 98.11(1), gamma = 93.55(1)degrees, V = 1490.0(3) Angstrom(3), Z = 4 and dcal = 1.406 Mg/m(3), R = 0.062 (wR = 0.165) for 388 parameters and 3094 observations with I greater than or equal to 2sigma(I). The compound 2 crystallized having two molecules in the asymmetric unit, which can be regarded as monohydrated dimers, and forming a hydrate. The conformation of the central heterocyclic ring (1,4-dihydropyrimidine) in both compounds was found to be close to a half-chair conformation. The 2-nitrophenyl substituent in 2 is in the axial synperiplanar orientation. In both compounds, the conformation of the 3-substituted carbamoyl group appears to be influenced by hydrogen bonding with anticlinal orientation observed for carbonyl groups serving as hydrogen bonding acceptors.
引用
收藏
页码:113 / 121
页数:9
相关论文
共 28 条
[1]   SYNTHESIS AND CHROMATOGRAPHIC-SEPARATION OF THE STEREOISOMERS OF FURNIDIPINE [J].
ALAJARIN, R ;
ALVAREZBUILLA, J ;
VAQUERO, JJ ;
SUNKEL, C ;
DECASAJUANA, MF ;
STATKOW, PR ;
SANZAPARICIO, J .
TETRAHEDRON-ASYMMETRY, 1993, 4 (04) :617-620
[2]   DIHYDROPYRIMIDINE CALCIUM-CHANNEL BLOCKERS .3. 3-CARBAMOYL-4-ARYL-1,2,3,4-TETRAHYDRO-6-METHYL-5-PYRIMIDINECARBOXYLIC ACID-ESTERS AS ORALLY EFFECTIVE ANTIHYPERTENSIVE AGENTS [J].
ATWAL, KS ;
SWANSON, BN ;
UNGER, SE ;
FLOYD, DM ;
MORELAND, S ;
HEDBERG, A ;
OREILLY, BC .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :806-811
[3]   DIHYDROPYRIMIDINE CALCIUM-CHANNEL BLOCKERS .2. 3-SUBSTITUTED-4-ARYL-1,4-DIHYDRO-6-METHYL-5-PYRIMIDINECARBOXYLIC ACID-ESTERS AS POTENT MIMICS OF DIHYDROPYRIDINES [J].
ATWAL, KS ;
ROVNYAK, GC ;
KIMBALL, SD ;
FLOYD, DM ;
MORELAND, S ;
SWANSON, BN ;
GOUGOUTAS, JZ ;
SCHWARTZ, J ;
SMILLIE, KM ;
MALLEY, MF .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) :2629-2635
[4]  
BIDYASAGAR M, 1998, Z KRISTALLOGR, V213, P182
[5]  
BIDYASAGAR M, 1999, J CHEM CRYSTALLOGR, V29, P481
[6]   DIHYDROPYRIMIDINES - NOVEL CALCIUM-ANTAGONISTS WITH POTENT AND LONG-LASTING VASODILATIVE AND ANTIHYPERTENSIVE ACTIVITY [J].
CHO, H ;
UEDA, M ;
SHIMA, K ;
MIZUNO, A ;
HAYASHIMATSU, M ;
OHNAKA, Y ;
TAKEUCHI, Y ;
HAMAGUCHI, M ;
AISAKA, K ;
HIDAKA, T ;
KAWAI, M ;
TAKEDA, M ;
ISHIHARA, T ;
FUNAHASHI, K ;
SATOH, F ;
MORITA, M ;
NOGUCHI, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (10) :2399-2406
[7]  
Duax W. L., 1975, ATLAS STEROID STRUCT, V2
[8]   CRYSTAL-STRUCTURES AND PHARMACOLOGICAL ACTIVITY OF CALCIUM-CHANNEL ANTAGONISTS - 2,6-DIMETHYL-3,5-DICARBOMETHOXY-4-(UNSUBSTITUTED, 3-METHYL-PHENYL, 4-METHYL-PHENYL, 3-NITRO-PHENYL, 4-NITRO-PHENYL, AND 2,4-DINITROPHENYL)-1,4-DIHYDROPYRIDINE [J].
FOSSHEIM, R ;
SVARTENG, K ;
MOSTAD, A ;
ROMMING, C ;
SHEFTER, E ;
TRIGGLE, DJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (02) :126-131
[9]   1,4-DIHYDROPYRIDINES - EFFECTS OF CHIRALITY AND CONFORMATION ON THE CALCIUM-ANTAGONIST AND CALCIUM AGONIST ACTIVITIES [J].
GOLDMANN, S ;
STOLTEFUSS, J .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1991, 30 (12) :1559-1578
[10]   PHARMACOLOGICAL PROFILE OF THE DIHYDROPYRIMIDINE CALCIUM-CHANNEL BLOCKERS SQ-32,547 AND SQ-32,946 [J].
GROVER, GJ ;
DZWONCZYK, S ;
MCMULLEN, DM ;
NORMANDIN, DE ;
PARHAM, CS ;
SLEPH, PG ;
MORELAND, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1995, 26 (02) :289-294